{"name":"Processa Pharmaceuticals","slug":"processa-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":5000,"revenueGrowth":-95.6,"grossMargin":0,"rdSpend":5799518,"netIncome":-13563834,"cash":7813567,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2016"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQMDhETS1lVXliVm5ra1RHMGJOdWp5bzh3SGRxUUdzSkp6QmNadTFLYzMxTy1peVZMQ3Q0b2VZLWF5SDQwendMLUU3d2NZRHIxaG1OSjhDbDhUQm96dGpPZFkyUDlfaVhLNmpEZENhSi1XNk82MUNyMndtYkFCdTJnbEhzbk1mVEhTSWpYT1ZNOXJYbmZDZEhqOEl1MkdodXp4b2lLbkE5NlQwYk81eExfSGVzNmNkaDFiNnduZXQ3MA?oc=5","date":"2026-04-01","type":"deal","source":"Stock Titan","summary":"Processa (NASDAQ: PCSA) CDO buys 2,107 shares in open-market trade - Stock Titan","headline":"Processa (NASDAQ: PCSA) CDO buys 2,107 shares in open-market trade","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQUlhpbHNrS1dHZ0xUOUhIcUg2M0lxWjVZSXNQaEZ5T3Uta2ljRlk2Vlg2ZUJVZHdCcmVUNUotWVlZUlU4djR0OGdnRHFfVmdla1hzUTc2b2FDcFdOMVZXVWQ5WndreUtkaGJYZ1QyUnc3ejZLVGdsa2FpUE1tZDVQRFFoOGNaWjZvQVhVSWRiVG90RHlyd1pyZl91NGpybktCMFVVUmQwaEhjczZyRGNnaXR3cXN4azBZb3NQMkpKZTVFNVU?oc=5","date":"2026-04-01","type":"deal","source":"Investing.com","summary":"Processa Pharma chief business officer Lin buys $4063 in PCSA - Investing.com","headline":"Processa Pharma chief business officer Lin buys $4063 in PCSA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOeUJHSHVvaldEbjROMTJZbTVJcWU4S1NNYlQxNWhfRERTWUU1cV9lOGFDdS1NQVZjNUxOR2E5bE1fR2NQcXFLSThEd2FUbkRtdGZqOHIzakNzSF96TS1UN21uT0tsVnJfR0JIYk05c1p1eXVJX3UxNnB6eUFhemc1X015bWctSHhIclRwN3p3V3NwT29jYmlWRzZ6cV9nRk5ONzZFNGE5TS1uRGIyRW96QkxVY3NiXzJLS0Vz?oc=5","date":"2026-04-01","type":"deal","source":"Investing.com","summary":"Processa Pharma director Pannu buys $5,252 in PCSA stock - Investing.com","headline":"Processa Pharma director Pannu buys $5,252 in PCSA stock","sentiment":"neutral"},{"date":"2026-03-18","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-19","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxOODFaNGFUMVU3SmZwc0tVbE8zN3Uzdm0tdFhjOXl2ajVBMzRLME5wRlNIWGdNdFMxazVCa1BtTnNsY0hnay1TNm8xZ19LcEQ5TktNODBFLTJHUFJnUGJMNHJUMWRZSlNqYi1razU5N1ZqZ0trcFpDeEVWaklvMGp3a3B4bnRRSlZ0OUF0Nll0UXRLb3poRThjeVB0S1lLNnNBN2xvZ21WM2VlblZSOVJZejdwTmZSWFRIVW1OT2NiZjNPTFNoVTgxSFpNX0xpdk1ldVN5TDdCdHZUbVB1dGx4VUlmZTZMbV9la3dWQw?oc=5","date":"2025-12-18","type":"trial","source":"TechStock²","summary":"Processa Pharmaceuticals (PCSA) Stock: Phase 2 Breast Cancer Update, 1-for-25 Reverse Split, and What Wall Street Is Watching on Dec. 18, 2025 - TechStock²","headline":"Processa Pharmaceuticals (PCSA) Stock: Phase 2 Breast Cancer Update, 1-for-25 Reverse Split, and What Wall Street Is Wat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxOSVVxNHg0eFhTQmYxTDdmdUtqai1lX0xXVVh5NFplYVB1ZEk1ZjVaRlJSbXNwRWM3X0pHclRqZmFaYkdzNFl0TzRYOTg1bjJ4VFZSUUoyS1J6NTAyOUUtanZFckhsOEVWRGtDRWtPMWFEYnh5S2h6Nzk5T2RtSFhpUWZQdnVHWXE1VGNudDkwZGFVSzlnNU9UQTJxRlBod21ndnh4WFhNMFpDdnFxdU81WU9qTllKM1FiajQxa1ktbi1lNVBGTlhOVTlTT0VkZFdoUkhrcVUtWE4tSm1uZ1lRS2UxdmNPNTJxaGpJSzVuX2VpNzZ1MWFkdFp3?oc=5","date":"2025-12-17","type":"trial","source":"GlobeNewswire","summary":"Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer - GlobeNewswire","headline":"Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxPZXZQUHhPMlFhVENGLXl4OVVGeUczR3p5S0VCY2NzbnJkT2ZqcVZjR2ViaXVGTVEwOFpYajd6N1pIN3lRbVhjdmhCTEVzSmhLQjdWS0FmOTBnbzI2di1YRzZONktYVXloc2R4Q2N4dmJ0YXVwbEdmck9MeXhwWnhhUldpT2ZrY0hQT2RYMUF2dFVKVFREclpMRVo0Y0FfRVUzRC1kOXNueE5ZRWxIMllpTm91N3d5b21TYXpWd1hoUXRxUWlGWmZHeThWbDJPekFHQm00TVRnVHJXbnBS?oc=5","date":"2025-12-17","type":"trial","source":"Benzinga","summary":"Why Is Small-Cap Processa Pharmaceuticals Stock Rallying After Breast Cancer Trial Data? - Benzinga","headline":"Why Is Small-Cap Processa Pharmaceuticals Stock Rallying After Breast Cancer Trial Data?","sentiment":"neutral"},{"date":"2025-12-15","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-27","type":"pipeline","source":"GlobeNewswire","summary":"Gastroparesis Market Poised for Extraordinary Growth at a - GlobeNewswire","headline":"Gastroparesis Market Poised for Extraordinary Growth at a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPZmhyMGY3Z3U1TjhRLVl1UjktZzJieU1KRDB0aW10SjRqeFp2RW5xNUVKZFh2YVhIbm8tOHFsUzBsVUtId1JYWmV2VnJOc1RTSUJJSXBreXFmSHI0TVdHQ21fZEVjQ3pnX1V1WWtzNlJmdnpSS3hyMFdWRVdfbG04eGFVQ0NiTll2YndzcUx6V1dwUEczMUg0dXhwQVZtN1I0UWZhRDQyMkFzUlgtVTBTaWgxUDMwUzA?oc=5","date":"2025-10-08","type":"pipeline","source":"Benzinga","summary":"Why Processa Pharmaceuticals Stock Rose Almost 38% Overnight? - Processa Pharma (NASDAQ:PCSA) - Benzinga","headline":"Why Processa Pharmaceuticals Stock Rose Almost 38% Overnight? - Processa Pharma (NASDAQ:PCSA)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQdzFpSE1yTHo4bG5Td1VOUTVFeHhxRjZzSTJSb2xDQjBsWjVWMUdSVDJQWERwTXozQTFuakpSTjFwQnVQUHllRmFmeC00UlhXdUtyVVpYRlhiOGFvSzNzSUxoUjROekVzejlsdmQ3Rmt4eTBhWjdQVmtJWkdQOF9JYVY1N1QtRVppZkNZaWFyZU1oNnZRRHQ2YVNQTV9ST1FnRkNjaUs5UEhLUHhw?oc=5","date":"2025-07-01","type":"pipeline","source":"Fierce Biotech","summary":"Processa hands cancer candidate back to Opus Genetics after deciding milestone out of reach - Fierce Biotech","headline":"Processa hands cancer candidate back to Opus Genetics after deciding milestone out of reach","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQRWdNNENHRGc5dVkwWUNOWW9Ka19hWVExYzVhZFJrd2xHMlVxT3RPUzdDMUlRYVNIY2xtWU9CcWZwMkhXbDJReTdRNUJreVBIMlNKTUVjZlpoVGpPQThhMW1hR1ZKR1VvS1NmYlk2eDhuSG1oLVhZeDRMT3kyZWNqWFZxcHp4bHVIOXpQMGJDS3plMXJBbUtOdGRn?oc=5","date":"2025-06-20","type":"pipeline","source":"Medical Marketing and Media","summary":"Rx Rundown: Sanofi, Processa Pharmaceuticals, Eli Lilly and more - Medical Marketing and Media","headline":"Rx Rundown: Sanofi, Processa Pharmaceuticals, Eli Lilly and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQeUpQa3F4ZVhkSVV5TkxOQ25nN25kZ2Z1czZ6cmg4MHlHQjI5Ym5QT25EX1F5YnlXanpMNmROREtXVnctaDBzaFNGVU04dE9aMjJxWHh3SERfOWZaTHNtV2tBUlR6MUhTcElxcFBpVzhYZ0dKQndRbmNUOUhCRGdfQ3B1dXZUNVE0NFJxR2xlWlVqWTdz?oc=5","date":"2025-06-17","type":"pipeline","source":"Yahoo Finance","summary":"Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering - Yahoo Finance","headline":"Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":5000,"revenuePeriod":"2016-12-31","revenueHistory":[{"value":5000,"period":"2016-12-31"},{"value":113425,"period":"2015-12-31"},{"value":113425,"period":"2015-12-31"},{"value":200201,"period":"2014-12-31"},{"value":107239,"period":"2014-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":5799518,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-13563834,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":7813567,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}